Target intelligence / Profile preview

Paracrine growth factor and cytokine pathways

Molecular classification
Pathway, Cell signaling system
01

Overview

Paracrine growth factor and cytokine pathways represent a fundamental mode of intercellular communication where cells secrete signaling molecules that act on nearby target cells within the local environment. These pathways involve a vast array of ligands, including cytokines (e.g., interleukins, interferons) and growth factors (e.g., VEGF, FGF), which bind to specific cell-surface receptors to initiate intracellular signaling cascades (Alberts et al., Molecular Biology of the Cell). In physiological contexts, these pathways are essential for coordinating immune responses, promoting tissue repair, and regulating cell proliferation. However, their dysregulation is a hallmark of various pathologies; for example, in the tumor microenvironment, aberrant paracrine signaling facilitates angiogenesis and immune evasion, while overactive cytokine loops drive chronic inflammation and autoimmunity (Nature Reviews Drug Discovery, 2020). Because this term describes a broad biological mechanism rather than a single protein or receptor, it is not classified as a specific therapeutic target. Instead, clinical interventions focus on modulating individual components of these pathways, such as using monoclonal antibodies to neutralize specific cytokines or small-molecule inhibitors to block receptor tyrosine kinase activity (PubMed, PMID: 32111600).

Other names
Paracrine signalingCytokine signalingGrowth factor signalingLocal intercellular signaling
02

Mechanism of action

Inhibition of specific ligand-receptor interactions or downstream signaling cascades within local tissue environments.

03

Biological functions

Cell-to-cell communicationSignal transductionImmune responseCell proliferationTissue repair
04

Disease associations

CancerInflammationAutoimmune diseaseFibrosis
05

Safety considerations

Infection risk due to immunosuppressionDelayed wound healingSystemic toxicityCytokine release syndrome
06

Interacting drugs

Infliximab

4 more in the full profile.

07

Biomarkers

Serum cytokine levelsGrowth factor expressionPhospho-protein signaling assays

Beyond the preview

Go deeper on Paracrine growth factor and cytokine pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine growth factor and cytokine pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call